An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal Cancer
NCT ID: NCT03415815
Last Updated: 2018-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3673 participants
OBSERVATIONAL
2017-12-12
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence of 107 Lymph Node Metastasis
NCT07165184
Incidence of 106TBL Lymph Node Metastasis
NCT07165210
Machine Learning to Predict Lymph Node Metastasis in T1 Esophageal Squamous Cell Carcinoma
NCT06256185
Improve the Treatment of Thoracic Esophageal Cancer
NCT01137123
Precisely Estimation of the Prognostic Value of Lymph Node in ESCC
NCT04764240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
T1-T3 esophageal cancer
Pathologically diagnosed patients with T1-T3 esophageal cancer who received surgeries
Surgeries
Radical resection of esophageal cancer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgeries
Radical resection of esophageal cancer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who received radical resection of esophageal cancer;
* Pathologically diagnosed patients with thoracic T1-T3 esophageal cancer after surgeries;
Exclusion Criteria
* Patients with second primary tumors;
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
LinkDoc Technology (Beijing) Co. Ltd.
INDUSTRY
Henan Cancer Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yin Li
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yin Li
Role: PRINCIPAL_INVESTIGATOR
Henan Cancer Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
China PLA General Hospital
Beijing, Beijing Municipality, China
Henan cancer hospital
Zhengzhou, Henan, China
Tongji Hospital Affiliated to Huazhong Technology Hospital
Wuhan, Hubei, China
Jiangsu cancer hospital
Nanjing, Jiangsu, China
Xi'an Tangdu Hospital
Xi'an, Shaanxi, China
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China
Huaxi Hospital Affiliated to Sichuan University
Chengdu, Sichuan, China
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China
First Hospital Affiliated to Zhejiang University
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Deruo Liu, PhD
Role: primary
Yang Liu, PhD
Role: primary
Yin Li, PhD
Role: primary
Yin Li, PhD
Role: primary
Lin Xu, PhD
Role: primary
Xiaofei Li, PhD
Role: primary
Heng Zhao, PhD
Role: primary
Lunxu Liu, PhD
Role: primary
Xun Zhang, PhD
Role: primary
Jian Hu, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HenanEC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.